Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
Minoru Nakamura(Hokkaido University of Science), Hiromi Ishibashi(Nagasaki Medical Center), Michiaki Koga(National Hospital Organization), Seigo Abiru(Nagasaki Medical Center), Yukio Watanabe(Juntendo University), Yoko Nakamura(Nagasaki Medical Center), Naohiko Masaki(National Center for Global Health and Medicine), Eiichi Takezaki(National Hospital Organization), Koichi Honda(Yamagata University), Akira Saito(StaGen (Japan)), Terufumi Yokoyama(Nagasaki Medical Center), Makiko Koyabu(Nagasaki Medical Center), Kiyoshi Migita(Fukushima Medical University), Hideharu Harada(National Hospital Organization), Hiroshi Yatsuhashi(Nagasaki Medical Center), Zakera Shums(Nova Medical (United States)), Masakazu Kobayashi(Kyoto University Hospital), Kazuhiro Sugi(Nagasaki Medical Center), Toyokichi Muro(Nagasaki Medical Center), Gary L. Norman(Nova Medical (United States)), Atsumasa Komori, Yasushi Takii(Nagasaki Medical Center), Masahiro Ito(Nagasaki Medical Center), Tetsuo Yamamoto(National Hospital Organization), Masaaki Shimada(Nagasaki Medical Center), Hironori Sakai(National Hospital Organization), Hiroshi Adachi(The University of Osaka), Takeshi Sodeyama(Shinshu University), Shigeki Hayashi(National Hospital Organization), Mutsumi Matsuyama(Nagasaki University), Hidehiro Nishi(National Hospital Organization), Akihide Masumoto(Aso Iizuka Hospital), Manabu Daikoku(Nagasaki Medical Center), Hisayoshi Kondo(Nagasaki University), Takeo Saoshiro(National Hospital Organization), Takehiro Sando(National Hospital Organization), Tatsuji Komatsu(Nagasaki Medical Center), Tsuyoshi Mori(Nagasaki Medical Center)
Cited by 365
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
|Hepatology|1990|1.2k
Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.
|PubMed|1994|290
Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores
|Nature Genetics|2022|279
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272